Fundraising Fox
Invitrall
Founded 2024 · 4 employees on LinkedIn · 1 known investors
Find your way into Invitrall
Each arrow is one introduction. Sign up to fill in the first one.
Ask Gabriel Mantovani Bottos to introduce you to Gabriel Lohn Costa
You →Gabriel · together at Vesper Ventures →Gabriel
Sign up to find every way you can get introduced to Invitrall
- Your email: who you already know at Invitrall, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Invitrall team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Invitrall develops long-lasting, disease-representative human skin organoids from reprogrammed human cells, combining cell reprogramming, organoids, and machine learning to create human preclinical models. Its platform supports efficacy and repeated-dose toxicity testing for pharmaceutical and dermocosmetics companies developing skin drugs and cosmetics, as an alternative to animal testing.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Invitrall do?
- Invitrall develops long-lasting, disease-representative human skin organoids from reprogrammed human cells, combining cell reprogramming, organoids, and machine learning to create human preclinical models. Its platform supports efficacy and repeated-dose toxicity testing for pharmaceutical and dermocosmetics companies developing skin drugs and cosmetics, as an alternative to animal testing.
- Who are Invitrall's investors?
- Invitrall's investors include GRIDX.